Joshua Ward, DPM
Foot Surgery · San Antonio, TXNPI 1750919684
Payments from drug & device makers
What this record shows
14 manufacturers reported payments, led by Vilex LLC at 27.0% of the total. Reporting peaked in 2023 at $3,288 and has fallen 88.9% since, to $364 in 2025.
Across 50 payments — averaging $106.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vilex LLC$1K
- Stryker$1K
- Biotissue Holdings Inc.$1K
- Amgen$337
- Trilliant Surgical LLC.$318
- Mission Medical Distribution, LLC$274
- plus $523 from 8 others
What the payments were for
- Travel & lodging$2,83453%
- Food & beverage$2,48347%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vilex LLC | 5 | $1,436 |
| Stryker | 12 | $1,324 |
| Biotissue Holdings Inc. | 14 | $1,105 |
| Amgen | 1 | $337 |
| Trilliant Surgical LLC. | 6 | $318 |
| Mission Medical Distribution, LLC | 2 | $274 |
| Paragon 28, Inc. | 2 | $206 |
| Integra Lifesciences Corporation | 1 | $125 |
| Convatec Inc. | 1 | $85 |
| IBSA Pharma Inc. | 2 | $41 |
| Nevro Corp. | 1 | $22 |
| Orthofix Medical, Inc. | 1 | $17 |
| Smith+Nephew | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HINTERMANN$1,230
- PROstep$923
- NEOX$219
- CLARIX$219
- Bun-Yo-Matic$156
- PROPHECY$140
- TENOGLIDE$125
- Arsenal Ankle 10 Hole 1/3 Tubular Plate$103
How this compares
$5,317 in reported general payments places this provider in the 65th percentile of 71 foot surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 48 | $823 |
| Ciclopirox | 15 | $604 |
| Diclofenac Sodium ErDiclofenac Sodium | 17 | $509 |
| Doxycycline Hyclate | 11 | $106 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in San Antonio
- Marque AllenSan Antonio$204K
- Lawrence LaverySan Antonio$59K
- Richard KehSan Antonio$17K
- Seth AshrafSan Antonio$17K
- Kris FordSan Antonio$15K
- Jonathan LorenzanaSan Antonio$4K
- Caroline GaynorSan Antonio$2K
- Jason MirelesSan Antonio$1K
- Marvin SanchezSan Antonio$614
- W Brent GillespieSan Antonio$383
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.